JP2007529486A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007529486A5 JP2007529486A5 JP2007503404A JP2007503404A JP2007529486A5 JP 2007529486 A5 JP2007529486 A5 JP 2007529486A5 JP 2007503404 A JP2007503404 A JP 2007503404A JP 2007503404 A JP2007503404 A JP 2007503404A JP 2007529486 A5 JP2007529486 A5 JP 2007529486A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- aminocarbonyl
- amino
- ethyl
- pyrazolo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000000217 alkyl group Chemical group 0.000 claims 39
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 32
- 150000003839 salts Chemical class 0.000 claims 31
- 150000001875 compounds Chemical class 0.000 claims 27
- 125000003709 fluoroalkyl group Chemical group 0.000 claims 20
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 16
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 16
- -1 4- (aminocarbonyl) cyclohexyl Chemical group 0.000 claims 15
- 229910052799 carbon Inorganic materials 0.000 claims 11
- 125000004428 fluoroalkoxy group Chemical group 0.000 claims 11
- 229910052757 nitrogen Inorganic materials 0.000 claims 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 10
- 125000003545 alkoxy group Chemical group 0.000 claims 9
- 125000001424 substituent group Chemical group 0.000 claims 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 6
- 125000005843 halogen group Chemical group 0.000 claims 6
- 229910052760 oxygen Inorganic materials 0.000 claims 6
- 230000002265 prevention Effects 0.000 claims 6
- 125000004076 pyridyl group Chemical group 0.000 claims 6
- 241000124008 Mammalia Species 0.000 claims 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 5
- 229910052717 sulfur Inorganic materials 0.000 claims 5
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 4
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 4
- 125000001309 chloro group Chemical group Cl* 0.000 claims 4
- 125000001153 fluoro group Chemical group F* 0.000 claims 4
- 125000000623 heterocyclic group Chemical group 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 208000028698 Cognitive impairment Diseases 0.000 claims 3
- 208000010877 cognitive disease Diseases 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 229910052731 fluorine Inorganic materials 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 3
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 2
- 206010012438 Dermatitis atopic Diseases 0.000 claims 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 2
- 201000004681 Psoriasis Diseases 0.000 claims 2
- 206010039085 Rhinitis allergic Diseases 0.000 claims 2
- 206010040070 Septic Shock Diseases 0.000 claims 2
- 125000005037 alkyl phenyl group Chemical group 0.000 claims 2
- 208000026935 allergic disease Diseases 0.000 claims 2
- 201000010105 allergic rhinitis Diseases 0.000 claims 2
- 208000006673 asthma Diseases 0.000 claims 2
- 201000008937 atopic dermatitis Diseases 0.000 claims 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 2
- 150000001721 carbon Chemical group 0.000 claims 2
- 229910052801 chlorine Inorganic materials 0.000 claims 2
- 239000000460 chlorine Substances 0.000 claims 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 2
- 239000011737 fluorine Substances 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims 2
- 208000027866 inflammatory disease Diseases 0.000 claims 2
- 230000002757 inflammatory effect Effects 0.000 claims 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- ZCGIZZQSUIMIHI-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-1-ethyl-n-[(2-methylsulfonylphenyl)methyl]pyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=CC=C(S(C)(=O)=O)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 ZCGIZZQSUIMIHI-UHFFFAOYSA-N 0.000 claims 1
- RRKVLHFICMHKAU-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-1-ethyl-n-[(2-phenylphenyl)methyl]pyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=CC=C(C=2C=CC=CC=2)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 RRKVLHFICMHKAU-UHFFFAOYSA-N 0.000 claims 1
- VKGDMPYFFNTXIP-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-1-ethyl-n-[(2-thiophen-3-ylphenyl)methyl]pyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=CC=C(C2=CSC=C2)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 VKGDMPYFFNTXIP-UHFFFAOYSA-N 0.000 claims 1
- RVBSJFDPBSNUKY-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-1-ethyl-n-[(3-hydroxyphenyl)methyl]pyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=CC(O)=CC=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 RVBSJFDPBSNUKY-UHFFFAOYSA-N 0.000 claims 1
- SSDUIGZUKOZTLV-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-1-ethyl-n-[(3-phenylphenyl)methyl]pyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=CC(C=2C=CC=CC=2)=CC=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 SSDUIGZUKOZTLV-UHFFFAOYSA-N 0.000 claims 1
- QOLXDQSYFFMQBJ-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-1-ethyl-n-[(4-hydroxyphenyl)methyl]pyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(O)C=CC=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 QOLXDQSYFFMQBJ-UHFFFAOYSA-N 0.000 claims 1
- OOQIKOXSZKAPBA-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-1-ethyl-n-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(OC)C=CC=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 OOQIKOXSZKAPBA-UHFFFAOYSA-N 0.000 claims 1
- JKBKBTQUFUUQHB-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-1-ethyl-n-[(4-methyl-2-phenylphenyl)methyl]pyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(C)C=C(C=2C=CC=CC=2)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 JKBKBTQUFUUQHB-UHFFFAOYSA-N 0.000 claims 1
- AXYLEUAQFJXWHA-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-1-ethyl-n-[(4-methyl-2-thiophen-3-ylphenyl)methyl]pyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(C)C=C(C2=CSC=C2)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 AXYLEUAQFJXWHA-UHFFFAOYSA-N 0.000 claims 1
- HOAQYVZDYYVWST-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-1-ethyl-n-[(4-methylsulfonylphenyl)methyl]pyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(S(C)(=O)=O)C=CC=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 HOAQYVZDYYVWST-UHFFFAOYSA-N 0.000 claims 1
- KLUJSOAEXLKTQR-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-1-ethyl-n-[(4-phenylphenyl)methyl]pyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 KLUJSOAEXLKTQR-UHFFFAOYSA-N 0.000 claims 1
- MLQIBLQASLHAIB-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-1-ethyl-n-[[2-(3-methoxyphenyl)phenyl]methyl]pyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=CC=C(C=2C=C(OC)C=CC=2)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 MLQIBLQASLHAIB-UHFFFAOYSA-N 0.000 claims 1
- CAZIEIOJEFAQAI-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-1-ethyl-n-[[2-(4-methoxyphenyl)phenyl]methyl]pyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=CC=C(C=2C=CC(OC)=CC=2)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 CAZIEIOJEFAQAI-UHFFFAOYSA-N 0.000 claims 1
- NSFGYOIAQQMSLJ-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-1-ethyl-n-[[2-(4-methylphenyl)phenyl]methyl]pyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=CC=C(C=2C=CC(C)=CC=2)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 NSFGYOIAQQMSLJ-UHFFFAOYSA-N 0.000 claims 1
- YLDKFPQBFNZWME-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-1-ethyl-n-[[2-(4-methylthiophen-3-yl)phenyl]methyl]pyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=CC=C(C=2C(=CSC=2)C)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 YLDKFPQBFNZWME-UHFFFAOYSA-N 0.000 claims 1
- NBOBGJJASYAUHK-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-1-ethyl-n-[[2-(6-methoxypyridin-3-yl)phenyl]methyl]pyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=CC=C(C=2C=NC(OC)=CC=2)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 NBOBGJJASYAUHK-UHFFFAOYSA-N 0.000 claims 1
- PTNSMCSLHIURCU-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-1-ethyl-n-[[2-(furan-3-yl)-4-methylphenyl]methyl]pyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(C)C=C(C2=COC=C2)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 PTNSMCSLHIURCU-UHFFFAOYSA-N 0.000 claims 1
- NOYJKXILZLBGKN-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-1-ethyl-n-[[2-(furan-3-yl)phenyl]methyl]pyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=CC=C(C2=COC=C2)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 NOYJKXILZLBGKN-UHFFFAOYSA-N 0.000 claims 1
- FTTFVVYHMDYKAX-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-1-ethyl-n-[[2-[4-(trifluoromethyl)phenyl]phenyl]methyl]pyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=CC=C(C=2C=CC(=CC=2)C(F)(F)F)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 FTTFVVYHMDYKAX-UHFFFAOYSA-N 0.000 claims 1
- XCGYWMVMTYWDOP-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-1-ethyl-n-[[4-(trifluoromethyl)phenyl]methyl]pyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(C(F)(F)F)C=CC=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 XCGYWMVMTYWDOP-UHFFFAOYSA-N 0.000 claims 1
- MMKQFSFNDADCJZ-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-1-ethyl-n-[[4-[4-(trifluoromethyl)phenyl]phenyl]methyl]pyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(C=2C=CC(=CC=2)C(F)(F)F)C=CC=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 MMKQFSFNDADCJZ-UHFFFAOYSA-N 0.000 claims 1
- JXRZWSQUOSKXAM-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-n-(2,3-dihydro-1-benzofuran-5-ylmethyl)-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C2OCCC2=CC=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 JXRZWSQUOSKXAM-UHFFFAOYSA-N 0.000 claims 1
- FWJFXKRPKMKQQY-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-n-[(2,3-dichlorophenyl)methyl]-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=CC(Cl)=C(Cl)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 FWJFXKRPKMKQQY-UHFFFAOYSA-N 0.000 claims 1
- IXEZTMCWGOHJAB-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-n-[(2,3-dimethylphenyl)methyl]-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=CC(C)=C(C)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 IXEZTMCWGOHJAB-UHFFFAOYSA-N 0.000 claims 1
- CZPPSFMUHHLSTN-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-n-[(2,4-difluorophenyl)methyl]-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(F)C=C(F)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 CZPPSFMUHHLSTN-UHFFFAOYSA-N 0.000 claims 1
- IBXXHMZGPKMWFQ-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-n-[(2,4-dimethylphenyl)methyl]-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(C)C=C(C)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 IBXXHMZGPKMWFQ-UHFFFAOYSA-N 0.000 claims 1
- RLXYAYUKDLFODG-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-n-[(4-chloro-2-fluorophenyl)methyl]-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(Cl)C=C(F)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 RLXYAYUKDLFODG-UHFFFAOYSA-N 0.000 claims 1
- BZTAWBQJELZTHC-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-n-[(4-chloro-2-methylphenyl)methyl]-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(Cl)C=C(C)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 BZTAWBQJELZTHC-UHFFFAOYSA-N 0.000 claims 1
- MRNLHCKEGOXGOC-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-n-[(4-chlorophenyl)methyl]-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(Cl)C=CC=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 MRNLHCKEGOXGOC-UHFFFAOYSA-N 0.000 claims 1
- NECDJYIINZIXOB-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-n-[[2-(3-chlorophenyl)-4-methylphenyl]methyl]-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(C)C=C(C=2C=C(Cl)C=CC=2)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 NECDJYIINZIXOB-UHFFFAOYSA-N 0.000 claims 1
- VEEXUMMZAMSUEQ-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-n-[[2-(3-chlorophenyl)phenyl]methyl]-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=CC=C(C=2C=C(Cl)C=CC=2)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 VEEXUMMZAMSUEQ-UHFFFAOYSA-N 0.000 claims 1
- PQZYADBVAQXZTG-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-n-[[2-(4-chlorophenyl)phenyl]methyl]-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=CC=C(C=2C=CC(Cl)=CC=2)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 PQZYADBVAQXZTG-UHFFFAOYSA-N 0.000 claims 1
- IZYMIEFEUVUJRZ-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-n-[[4-(4-chlorophenyl)phenyl]methyl]-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(C=2C=CC(Cl)=CC=2)C=CC=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 IZYMIEFEUVUJRZ-UHFFFAOYSA-N 0.000 claims 1
- GQDBELGEPMMTSN-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-n-[[4-(4-ethoxyphenyl)phenyl]methyl]-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C1=CC(OCC)=CC=C1C(C=C1)=CC=C1CNC(=O)C1=CN=C(N(CC)N=C2)C2=C1NC1CCN(C(N)=O)CC1 GQDBELGEPMMTSN-UHFFFAOYSA-N 0.000 claims 1
- GAXLSASSDIGOFT-UHFFFAOYSA-N 4-[(1-carbamoylpiperidin-4-yl)amino]-n-[[4-(difluoromethoxy)phenyl]methyl]-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(OC(F)F)C=CC=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 GAXLSASSDIGOFT-UHFFFAOYSA-N 0.000 claims 1
- YHQHRYOZGGVVEL-UHFFFAOYSA-N 4-[(4-carbamoylcyclohexyl)amino]-1-ethyl-n-(5,6,7,8-tetrahydronaphthalen-1-ylmethyl)pyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=CC=2CCCCC=2C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCC(C(N)=O)CC1 YHQHRYOZGGVVEL-UHFFFAOYSA-N 0.000 claims 1
- CRVVGOYOEQATGS-UHFFFAOYSA-N 4-[(4-carbamoylcyclohexyl)amino]-1-ethyl-n-[(2-methylsulfonylphenyl)methyl]pyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=CC=C(S(C)(=O)=O)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCC(C(N)=O)CC1 CRVVGOYOEQATGS-UHFFFAOYSA-N 0.000 claims 1
- ZOHQAQLVNBOMJA-UHFFFAOYSA-N 4-[(4-carbamoylcyclohexyl)amino]-1-ethyl-n-[(2-phenylphenyl)methyl]pyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=CC=C(C=2C=CC=CC=2)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCC(C(N)=O)CC1 ZOHQAQLVNBOMJA-UHFFFAOYSA-N 0.000 claims 1
- NHHXXRBFFFDJIC-UHFFFAOYSA-N 4-[(4-carbamoylcyclohexyl)amino]-1-ethyl-n-[(3-phenylphenyl)methyl]pyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=CC(C=2C=CC=CC=2)=CC=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCC(C(N)=O)CC1 NHHXXRBFFFDJIC-UHFFFAOYSA-N 0.000 claims 1
- OJLXNTLOKAZZAQ-UHFFFAOYSA-N 4-[(4-carbamoylcyclohexyl)amino]-1-ethyl-n-[(4-fluorophenyl)methyl]pyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(F)C=CC=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCC(C(N)=O)CC1 OJLXNTLOKAZZAQ-UHFFFAOYSA-N 0.000 claims 1
- TUNOSBIMXXHDBG-UHFFFAOYSA-N 4-[(4-carbamoylcyclohexyl)amino]-1-ethyl-n-[(4-hydroxyphenyl)methyl]pyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(O)C=CC=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCC(C(N)=O)CC1 TUNOSBIMXXHDBG-UHFFFAOYSA-N 0.000 claims 1
- JNOISAPWZIBULT-UHFFFAOYSA-N 4-[(4-carbamoylcyclohexyl)amino]-1-ethyl-n-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(OC)C=CC=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCC(C(N)=O)CC1 JNOISAPWZIBULT-UHFFFAOYSA-N 0.000 claims 1
- QWUFWAPKQIPTRU-UHFFFAOYSA-N 4-[(4-carbamoylcyclohexyl)amino]-1-ethyl-n-[(4-methylsulfonylphenyl)methyl]pyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(S(C)(=O)=O)C=CC=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCC(C(N)=O)CC1 QWUFWAPKQIPTRU-UHFFFAOYSA-N 0.000 claims 1
- VKKCBSFBUZIPAG-UHFFFAOYSA-N 4-[(4-carbamoylcyclohexyl)amino]-n-(2,3-dihydro-1-benzofuran-5-ylmethyl)-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C2OCCC2=CC=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCC(C(N)=O)CC1 VKKCBSFBUZIPAG-UHFFFAOYSA-N 0.000 claims 1
- LHOPAMILBHYQRQ-UHFFFAOYSA-N 4-[(4-carbamoylcyclohexyl)amino]-n-[(2,3-dichlorophenyl)methyl]-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=CC(Cl)=C(Cl)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCC(C(N)=O)CC1 LHOPAMILBHYQRQ-UHFFFAOYSA-N 0.000 claims 1
- LDMZHABVNPSYDI-UHFFFAOYSA-N 4-[(4-carbamoylcyclohexyl)amino]-n-[(2,3-dimethylphenyl)methyl]-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=CC(C)=C(C)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCC(C(N)=O)CC1 LDMZHABVNPSYDI-UHFFFAOYSA-N 0.000 claims 1
- GHWBUXCPUBXSGE-UHFFFAOYSA-N 4-[(4-carbamoylcyclohexyl)amino]-n-[(2,4-difluorophenyl)methyl]-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(F)C=C(F)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCC(C(N)=O)CC1 GHWBUXCPUBXSGE-UHFFFAOYSA-N 0.000 claims 1
- VSKMKPAUOYDIPE-UHFFFAOYSA-N 4-[(4-carbamoylcyclohexyl)amino]-n-[(2,4-dimethylphenyl)methyl]-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(C)C=C(C)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCC(C(N)=O)CC1 VSKMKPAUOYDIPE-UHFFFAOYSA-N 0.000 claims 1
- CECRSPVAYQMGJY-UHFFFAOYSA-N 4-[(4-carbamoylcyclohexyl)amino]-n-[(3,4-dimethoxyphenyl)methyl]-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(OC)C(OC)=CC=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCC(C(N)=O)CC1 CECRSPVAYQMGJY-UHFFFAOYSA-N 0.000 claims 1
- BPDFLLJTBNLZFQ-UHFFFAOYSA-N 4-[(4-carbamoylcyclohexyl)amino]-n-[(3,4-dimethylphenyl)methyl]-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(C)C(C)=CC=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCC(C(N)=O)CC1 BPDFLLJTBNLZFQ-UHFFFAOYSA-N 0.000 claims 1
- JTSMSRSHDMJWND-UHFFFAOYSA-N 4-[(4-carbamoylcyclohexyl)amino]-n-[(4-chloro-2-fluorophenyl)methyl]-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(Cl)C=C(F)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCC(C(N)=O)CC1 JTSMSRSHDMJWND-UHFFFAOYSA-N 0.000 claims 1
- FHCOVARSLZNSOT-UHFFFAOYSA-N 4-[(4-carbamoylcyclohexyl)amino]-n-[(4-chloro-2-methylphenyl)methyl]-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(Cl)C=C(C)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCC(C(N)=O)CC1 FHCOVARSLZNSOT-UHFFFAOYSA-N 0.000 claims 1
- YCLCHKXAMIXKMV-UHFFFAOYSA-N 4-[(4-carbamoylcyclohexyl)amino]-n-[(4-chlorophenyl)methyl]-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(Cl)C=CC=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCC(C(N)=O)CC1 YCLCHKXAMIXKMV-UHFFFAOYSA-N 0.000 claims 1
- QYDNUTKFQWNTGC-UHFFFAOYSA-N 4-[(4-carbamoylcyclohexyl)amino]-n-[[2,3-dichloro-6-(hydroxymethyl)phenyl]methyl]-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound OCC=1C=CC(Cl)=C(Cl)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCC(C(N)=O)CC1 QYDNUTKFQWNTGC-UHFFFAOYSA-N 0.000 claims 1
- QKWAXEJBIIWNFP-UHFFFAOYSA-N 4-[(4-carbamoylcyclohexyl)amino]-n-[[4-(4-chlorophenyl)phenyl]methyl]-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(C=2C=CC(Cl)=CC=2)C=CC=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCC(C(N)=O)CC1 QKWAXEJBIIWNFP-UHFFFAOYSA-N 0.000 claims 1
- VVUKHVQVRXLJQA-UHFFFAOYSA-N 4-[(4-carbamoylcyclohexyl)amino]-n-[[4-(difluoromethoxy)phenyl]methyl]-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(OC(F)F)C=CC=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCC(C(N)=O)CC1 VVUKHVQVRXLJQA-UHFFFAOYSA-N 0.000 claims 1
- MRHNGETWDSTSNW-KRWDZBQOSA-N 4-[[(3s)-1-carbamoylpyrrolidin-3-yl]amino]-n-[(2,4-dimethylphenyl)methyl]-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(C)C=C(C)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1N[C@H]1CCN(C(N)=O)C1 MRHNGETWDSTSNW-KRWDZBQOSA-N 0.000 claims 1
- PVINZTBQSANWMX-KRWDZBQOSA-N 4-[[(3s)-1-carbamoylpyrrolidin-3-yl]amino]-n-[(3,4-dimethylphenyl)methyl]-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=C(C)C(C)=CC=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1N[C@H]1CCN(C(N)=O)C1 PVINZTBQSANWMX-KRWDZBQOSA-N 0.000 claims 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims 1
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
- BPDFLLJTBNLZFQ-KDURUIRLSA-N C=1C=C(C)C(C)=CC=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1N[C@H]1CC[C@@H](C(N)=O)CC1 Chemical compound C=1C=C(C)C(C)=CC=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1N[C@H]1CC[C@@H](C(N)=O)CC1 BPDFLLJTBNLZFQ-KDURUIRLSA-N 0.000 claims 1
- VSKMKPAUOYDIPE-IZAXUBKRSA-N C=1C=C(C)C=C(C)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1N[C@H]1CC[C@@H](C(N)=O)CC1 Chemical compound C=1C=C(C)C=C(C)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1N[C@H]1CC[C@@H](C(N)=O)CC1 VSKMKPAUOYDIPE-IZAXUBKRSA-N 0.000 claims 1
- VSKMKPAUOYDIPE-UAPYVXQJSA-N C=1C=C(C)C=C(C)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1N[C@H]1CC[C@H](C(N)=O)CC1 Chemical compound C=1C=C(C)C=C(C)C=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1N[C@H]1CC[C@H](C(N)=O)CC1 VSKMKPAUOYDIPE-UAPYVXQJSA-N 0.000 claims 1
- JNOISAPWZIBULT-CALCHBBNSA-N C=1C=C(OC)C=CC=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1N[C@H]1CC[C@@H](C(N)=O)CC1 Chemical compound C=1C=C(OC)C=CC=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1N[C@H]1CC[C@@H](C(N)=O)CC1 JNOISAPWZIBULT-CALCHBBNSA-N 0.000 claims 1
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 206010010744 Conjunctivitis allergic Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 claims 1
- 206010014824 Endotoxic shock Diseases 0.000 claims 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 claims 1
- 206010065390 Inflammatory pain Diseases 0.000 claims 1
- 229930194542 Keto Natural products 0.000 claims 1
- 206010069698 Langerhans' cell histiocytosis Diseases 0.000 claims 1
- 208000012902 Nervous system disease Diseases 0.000 claims 1
- 208000025966 Neurological disease Diseases 0.000 claims 1
- 206010063837 Reperfusion injury Diseases 0.000 claims 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 208000024780 Urticaria Diseases 0.000 claims 1
- 208000011341 adult acute respiratory distress syndrome Diseases 0.000 claims 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 claims 1
- 125000004848 alkoxyethyl group Chemical group 0.000 claims 1
- 125000004849 alkoxymethyl group Chemical group 0.000 claims 1
- 125000005036 alkoxyphenyl group Chemical group 0.000 claims 1
- 208000002205 allergic conjunctivitis Diseases 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 208000024998 atopic conjunctivitis Diseases 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 150000003857 carboxamides Chemical class 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 125000000000 cycloalkoxy group Chemical group 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 208000003401 eosinophilic granuloma Diseases 0.000 claims 1
- 229910052740 iodine Inorganic materials 0.000 claims 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims 1
- 125000000468 ketone group Chemical group 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 230000002107 myocardial effect Effects 0.000 claims 1
- WRKBJPVSYBHBAR-UHFFFAOYSA-N n-benzyl-4-[(1-carbamoylpiperidin-4-yl)amino]-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=CC=CC=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCN(C(N)=O)CC1 WRKBJPVSYBHBAR-UHFFFAOYSA-N 0.000 claims 1
- DGFLLTZRHREVME-UHFFFAOYSA-N n-benzyl-4-[(4-carbamoylcyclohexyl)amino]-1-ethylpyrazolo[3,4-b]pyridine-5-carboxamide Chemical compound C=1C=CC=CC=1CNC(=O)C1=CN=C2N(CC)N=CC2=C1NC1CCC(C(N)=O)CC1 DGFLLTZRHREVME-UHFFFAOYSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000003386 piperidinyl group Chemical group 0.000 claims 1
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 1
- 125000006413 ring segment Chemical group 0.000 claims 1
- 230000036303 septic shock Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 208000018464 vernal keratoconjunctivitis Diseases 0.000 claims 1
- 0 *C(c(c(*)nc1c2cn[n]1I)c2N*)=O Chemical compound *C(c(c(*)nc1c2cn[n]1I)c2N*)=O 0.000 description 1
- SBQYIBYVXDQSPT-UHFFFAOYSA-N CC(CC1)CCN1C(N)=O Chemical compound CC(CC1)CCN1C(N)=O SBQYIBYVXDQSPT-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0405893A GB0405893D0 (en) | 2004-03-16 | 2004-03-16 | Compounds |
| GB0505214A GB0505214D0 (en) | 2005-03-14 | 2005-03-14 | Compounds |
| PCT/GB2005/000987 WO2005090354A1 (en) | 2004-03-16 | 2005-03-15 | PYRAZOLO[3,4-b] PYRIDINE COMPOUNDS, AND THEIR USE AS PDE4 INHIBITORS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007529486A JP2007529486A (ja) | 2007-10-25 |
| JP2007529486A5 true JP2007529486A5 (enExample) | 2008-05-01 |
Family
ID=34962723
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007503404A Pending JP2007529486A (ja) | 2004-03-16 | 2005-03-15 | ピラゾロ［３，４−ｂ］ピリジン化合物、およびＰＤＥ４阻害剤としてのその使用 |
| JP2007503306A Pending JP2007529464A (ja) | 2004-03-16 | 2005-03-15 | ビラゾロ［３，４−ｂ］ピリジン化合物及びＰＤＥ４阻害剤としてのその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007503306A Pending JP2007529464A (ja) | 2004-03-16 | 2005-03-15 | ビラゾロ［３，４−ｂ］ピリジン化合物及びＰＤＥ４阻害剤としてのその使用 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US7709497B2 (enExample) |
| EP (2) | EP1735314A1 (enExample) |
| JP (2) | JP2007529486A (enExample) |
| KR (1) | KR20060130744A (enExample) |
| AR (1) | AR048175A1 (enExample) |
| AU (1) | AU2005223351A1 (enExample) |
| BR (1) | BRPI0508843A (enExample) |
| CA (1) | CA2559629A1 (enExample) |
| IL (1) | IL178011A0 (enExample) |
| MA (1) | MA28531B1 (enExample) |
| NO (1) | NO20064450L (enExample) |
| PE (1) | PE20060078A1 (enExample) |
| RU (1) | RU2378274C2 (enExample) |
| TW (1) | TW200602051A (enExample) |
| WO (2) | WO2005090354A1 (enExample) |
Families Citing this family (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0230045D0 (en) | 2002-12-23 | 2003-01-29 | Glaxo Group Ltd | Compounds |
| WO2005058892A1 (en) * | 2003-12-19 | 2005-06-30 | Glaxo Group Limited | Pyrazolo [3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors |
| AU2005223351A1 (en) | 2004-03-16 | 2005-09-29 | Glaxo Group Limited | Pyrazolo[3,4-b]pyridine compound, and its use as a PDE4 inhibitor |
| KR20090003349A (ko) | 2006-04-20 | 2009-01-09 | 글락소 그룹 리미티드 | 화합물 |
| AR061571A1 (es) | 2006-06-23 | 2008-09-03 | Smithkline Beecham Corp | Compuesto sal del acido toluenosulfonico de 4-{[6-cloro-3-({[(2- cloro-3-fluorofenil) amino]carbonil} amino)- 2- hidroxifenil]sulfonil] -1- piperazinacarbxilato de 1.1-dimetiletilo, composicion farmaceutica que lo comprende su uso para la fabricacion de un medicamento combinacion farmaceutica con un |
| CA2659539A1 (en) | 2006-08-01 | 2008-02-07 | Glaxo Group Limited | Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors |
| PE20081889A1 (es) | 2007-03-23 | 2009-03-05 | Smithkline Beecham Corp | Indol carboxamidas como inhibidores de ikk2 |
| PE20091563A1 (es) | 2008-02-06 | 2009-11-05 | Glaxo Group Ltd | Farmacoforos duales - antagonistas muscarinicos de pde4 |
| PE20091553A1 (es) | 2008-02-06 | 2009-10-30 | Glaxo Group Ltd | Farmacoforos duales - antagonistas muscarinicos de pde4 |
| AR070562A1 (es) | 2008-02-06 | 2010-04-21 | Glaxo Group Ltd | Farmacoforos duales - antagonistas muscarinicos de pde4 |
| WO2009100169A1 (en) * | 2008-02-06 | 2009-08-13 | Glaxo Group Limited | Dual pharmacophores - pde4-muscarinic antagonistics |
| GB0806900D0 (en) * | 2008-04-16 | 2008-05-21 | Dow Corning | Fabric care emulsions |
| ES2566339T3 (es) | 2008-06-05 | 2016-04-12 | Glaxo Group Limited | Derivados de 4-carboxamida indazol útiles como inhibidores de PI3-quinasas |
| ES2433109T3 (es) | 2009-01-13 | 2013-12-09 | Glaxo Group Limited | Derivados de pirimidin-carboxamida como inhibidores de la Syk cinasa |
| US8524751B2 (en) | 2009-03-09 | 2013-09-03 | GlaxoSmithKline Intellecutual Property Development | 4-oxadiazol-2-YL-indazoles as inhibitors of P13 kinases |
| JP2012520257A (ja) | 2009-03-10 | 2012-09-06 | グラクソ グループ リミテッド | Ｉｋｋ２阻害剤としてのインドール誘導体 |
| EP2408769A1 (en) | 2009-03-17 | 2012-01-25 | Glaxo Group Limited | Pyrimidine derivatives used as itk inhibitors |
| SI2419087T1 (sl) * | 2009-04-13 | 2013-06-28 | Vanangamudi Subramaniam Sulur | Medicinska krema na osnovi fusidne kisline, izdelana z uporabo natrijevega fusidata in vsebujoča biopolimer in postopek za njeno izdelavo |
| CN102459253B (zh) | 2009-04-30 | 2015-03-25 | 葛兰素集团有限公司 | 作为pi3-激酶抑制剂的*唑取代的吲唑化合物 |
| US20120238559A1 (en) | 2009-12-03 | 2012-09-20 | Glaxo Group Limited | Novel compounds |
| WO2011067366A1 (en) | 2009-12-03 | 2011-06-09 | Glaxo Group Limited | Indazole derivatives as pi 3 - kinase inhibitors |
| EP2507223A1 (en) | 2009-12-03 | 2012-10-10 | Glaxo Group Limited | Benzpyrazole derivatives as inhibitors of p13 kinases |
| WO2011110575A1 (en) | 2010-03-11 | 2011-09-15 | Glaxo Group Limited | Derivatives of 2-[2-(benzo- or pyrido-) thiazolylamino]-6-aminopyridine, useful in the treatment of respiratoric, allergic or inflammatory diseases |
| WO2012032065A1 (en) | 2010-09-08 | 2012-03-15 | Glaxo Group Limited | Indazole derivatives for use in the treatment of influenza virus infection |
| JP5965402B2 (ja) | 2010-09-08 | 2016-08-03 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ | Ｎ−［５−［４−（５−｛［（２ｒ，６ｓ）−２，６−ジメチル−４−モルホリニル］メチル｝−１，３−オキサゾール−２−イル）−１ｈ−インダゾール−６−イル］−２−（メチルオキシ）−３−ピリジニル］メタンスルホンアミドの多形体および塩 |
| WO2012035055A1 (en) | 2010-09-17 | 2012-03-22 | Glaxo Group Limited | Novel compounds |
| GB201018124D0 (en) | 2010-10-27 | 2010-12-08 | Glaxo Group Ltd | Polymorphs and salts |
| CN104487864B (zh) | 2012-08-27 | 2017-06-23 | 伊莱克斯公司 | 机器人定位系统 |
| US10448794B2 (en) | 2013-04-15 | 2019-10-22 | Aktiebolaget Electrolux | Robotic vacuum cleaner |
| CN105101855A (zh) | 2013-04-15 | 2015-11-25 | 伊莱克斯公司 | 具有伸出的侧刷的机器人真空吸尘器 |
| US9011934B2 (en) | 2013-06-14 | 2015-04-21 | SatisPharma, LLC | Multi-purpose anti-itch treatment |
| EP3057587A1 (en) | 2013-10-17 | 2016-08-24 | GlaxoSmithKline Intellectual Property Development Limited | Pi3k inhibitor for treatment of respiratory disease |
| WO2015055691A1 (en) | 2013-10-17 | 2015-04-23 | Glaxosmithkline Intellectual Property Development Limited | Pi3k inhibitor for treatment of respiratory disease |
| EP3084540B1 (en) | 2013-12-19 | 2021-04-14 | Aktiebolaget Electrolux | Robotic cleaning device and operating method |
| JP6638988B2 (ja) | 2013-12-19 | 2020-02-05 | アクチエボラゲット エレクトロルックス | サイドブラシを有し、渦巻きパターンで動くロボットバキュームクリーナ |
| ES2675786T3 (es) | 2013-12-19 | 2018-07-12 | Aktiebolaget Electrolux | Control de velocidad adaptativo de cepillo lateral rotatorio |
| US10617271B2 (en) | 2013-12-19 | 2020-04-14 | Aktiebolaget Electrolux | Robotic cleaning device and method for landmark recognition |
| JP2017502371A (ja) | 2013-12-19 | 2017-01-19 | アクチエボラゲット エレクトロルックス | 掃除領域の優先順位付け |
| CN105813528B (zh) | 2013-12-19 | 2019-05-07 | 伊莱克斯公司 | 机器人清洁设备的障碍物感测爬行 |
| EP3084538B1 (en) | 2013-12-19 | 2017-11-01 | Aktiebolaget Electrolux | Robotic cleaning device with perimeter recording function |
| US10231591B2 (en) | 2013-12-20 | 2019-03-19 | Aktiebolaget Electrolux | Dust container |
| TW201625247A (zh) | 2014-05-12 | 2016-07-16 | 葛蘭素史密斯克藍智慧財產權有限公司 | 用於治療傳染性疾病之醫藥組合物 |
| CN106415423B (zh) | 2014-07-10 | 2021-01-01 | 伊莱克斯公司 | 用于检测机器人清洁装置的测量误差的方法 |
| WO2016037636A1 (en) | 2014-09-08 | 2016-03-17 | Aktiebolaget Electrolux | Robotic vacuum cleaner |
| US10499778B2 (en) | 2014-09-08 | 2019-12-10 | Aktiebolaget Electrolux | Robotic vacuum cleaner |
| US9452178B1 (en) | 2014-10-22 | 2016-09-27 | SatisPharma, LLC | Acne formulations, treatments, and pressure sensitive patches for delivery of acne formulations |
| WO2016091291A1 (en) | 2014-12-10 | 2016-06-16 | Aktiebolaget Electrolux | Using laser sensor for floor type detection |
| EP3229983B1 (en) | 2014-12-12 | 2019-02-20 | Aktiebolaget Electrolux | Side brush and robotic cleaner |
| EP3234714B1 (en) | 2014-12-16 | 2021-05-12 | Aktiebolaget Electrolux | Experience-based roadmap for a robotic cleaning device |
| KR102326401B1 (ko) | 2014-12-16 | 2021-11-16 | 에이비 엘렉트로룩스 | 로봇 청소 장치를 위한 청소 방법 |
| CN107405034B (zh) | 2015-04-17 | 2022-09-13 | 伊莱克斯公司 | 机器人清洁设备以及控制所述机器人清洁设备的方法 |
| CN107920709A (zh) | 2015-09-03 | 2018-04-17 | 伊莱克斯公司 | 机器人清洁设备系统 |
| KR20180083323A (ko) * | 2015-10-09 | 2018-07-20 | 애브비 에스.에이.알.엘. | N-설포닐화 피라졸로[3,4-b]피리딘-6-카복스아미드 및 사용 방법 |
| GB201602527D0 (en) | 2016-02-12 | 2016-03-30 | Glaxosmithkline Ip Dev Ltd | Chemical compounds |
| US11169533B2 (en) | 2016-03-15 | 2021-11-09 | Aktiebolaget Electrolux | Robotic cleaning device and a method at the robotic cleaning device of performing cliff detection |
| WO2017194102A1 (en) | 2016-05-11 | 2017-11-16 | Aktiebolaget Electrolux | Robotic cleaning device |
| JP2019524792A (ja) | 2016-08-08 | 2019-09-05 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ | 化合物 |
| GB201706102D0 (en) | 2017-04-18 | 2017-05-31 | Glaxosmithkline Ip Dev Ltd | Chemical compounds |
| CN110621208A (zh) | 2017-06-02 | 2019-12-27 | 伊莱克斯公司 | 检测机器人清洁设备前方的表面的高度差的方法 |
| GB201712081D0 (en) | 2017-07-27 | 2017-09-13 | Glaxosmithkline Ip Dev Ltd | Chemical compounds |
| KR20200058400A (ko) | 2017-09-26 | 2020-05-27 | 에이비 엘렉트로룩스 | 로봇 청소 장치의 이동 제어 |
| KR102034538B1 (ko) * | 2017-11-28 | 2019-10-21 | 주식회사한국파마 | Jak 저해제 화합물, 및 이의 제조방법 |
| CN111875594A (zh) * | 2020-07-21 | 2020-11-03 | 中国药科大学 | 具有磷酸二酯酶4b抑制活性的吲唑杂环类化合物 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3856799A (en) * | 1971-08-05 | 1974-12-24 | Squibb & Sons Inc | Intermediates for production of amino derivatives of pyrazolopyridine carboxylic acids and esters |
| BE787249A (fr) * | 1971-08-05 | 1973-02-05 | Squibb & Sons Inc | Derives amino d'acides pyrazolopyridine carboxyliques, leurs esters et les sels de ces composes, ainsi que leurs procedes de preparation |
| US3925388A (en) * | 1971-08-05 | 1975-12-09 | Squibb & Sons Inc | 4-Piperazino-{8 3,4-b{9 pyridine-5-carboxylic acids and esters |
| US3833594A (en) * | 1971-08-05 | 1974-09-03 | Squibb & Sons Inc | Amino derivatives of pyrazolopyridine carboxylic acids and esters |
| CA1003419A (en) | 1971-11-23 | 1977-01-11 | Theodor Denzel | Process for the production of pyrazolo (3,4-b) pyridines |
| US3979399A (en) * | 1972-11-15 | 1976-09-07 | E. R. Squibb & Sons, Inc. | Amino derivatives of pyrazolopyridine carboxamides |
| US3840546A (en) * | 1972-11-15 | 1974-10-08 | Squibb & Sons Inc | Amino derivatives of pyrazolopyridine carboxamides |
| US3833598A (en) | 1972-12-29 | 1974-09-03 | Squibb & Sons Inc | Amino derivatives of pyrazolopyridine-6-carboxylic acids and esters |
| US4115394A (en) | 1974-05-06 | 1978-09-19 | E. R. Squibb & Sons, Inc. | Amino derivatives of 6-phenylpyrazolo[3,4-b]pyridines |
| US4364948A (en) | 1981-09-28 | 1982-12-21 | Ici Americas Inc. | Pyrazolo[3,4-b]pyridine compounds |
| GB8425104D0 (en) | 1984-10-04 | 1984-11-07 | Ici America Inc | Amide derivatives |
| US5547954A (en) * | 1994-05-26 | 1996-08-20 | Fmc Corporation | 2,4-Diamino-5,6-disubstituted-and 5,6,7-trisubstituted-5-deazapteridines as insecticides |
| US5593997A (en) * | 1995-05-23 | 1997-01-14 | Pfizer Inc. | 4-aminopyrazolo(3-,4-D)pyrimidine and 4-aminopyrazolo-(3,4-D)pyridine tyrosine kinase inhibitors |
| US6326379B1 (en) | 1998-09-16 | 2001-12-04 | Bristol-Myers Squibb Co. | Fused pyridine inhibitors of cGMP phosphodiesterase |
| RU2134498C1 (ru) * | 1998-12-08 | 1999-08-10 | Таран Александр Иванович | Контактный узел |
| ES2258476T3 (es) | 1999-09-30 | 2006-09-01 | Neurogen Corporation | Ciertos heterociclos sustituidos con alquilendiaminas. |
| GB9929685D0 (en) | 1999-12-15 | 2000-02-09 | Merck Sharp & Dohme | Therapeutic agents |
| JP2002020386A (ja) * | 2000-07-07 | 2002-01-23 | Ono Pharmaceut Co Ltd | ピラゾロピリジン誘導体 |
| US6670364B2 (en) * | 2001-01-31 | 2003-12-30 | Telik, Inc. | Antagonists of MCP-1 function and methods of use thereof |
| BR0207302A (pt) | 2001-02-08 | 2004-02-10 | Memory Pharm Corp | Trifluorometilpurinas como inibidores da fosfodiesterase 4 |
| US6677365B2 (en) | 2001-04-03 | 2004-01-13 | Telik, Inc. | Antagonists of MCP-1 function and methods of use thereof |
| FR2828693B1 (fr) | 2001-08-14 | 2004-06-18 | Exonhit Therapeutics Sa | Nouvelle cible moleculaire de la neurotoxicite |
| US20050043319A1 (en) * | 2001-08-14 | 2005-02-24 | Exonhit Therapeutics Sa | Molecular target of neurotoxicity |
| GB0230045D0 (en) * | 2002-12-23 | 2003-01-29 | Glaxo Group Ltd | Compounds |
| MXPA05002887A (es) | 2002-09-16 | 2005-05-27 | Glaxo Group Ltd | Compuestos de pirazolo[3,4-b]piridina, y su uso como inhibidores de fosfodiesterasa. |
| US7117650B2 (en) * | 2002-12-09 | 2006-10-10 | Forrest Dockery | Hanger system |
| WO2005058892A1 (en) | 2003-12-19 | 2005-06-30 | Glaxo Group Limited | Pyrazolo [3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors |
| GB0405937D0 (en) | 2004-03-16 | 2004-04-21 | Glaxo Group Ltd | Compounds |
| AU2005223351A1 (en) | 2004-03-16 | 2005-09-29 | Glaxo Group Limited | Pyrazolo[3,4-b]pyridine compound, and its use as a PDE4 inhibitor |
| GB0405933D0 (en) | 2004-03-16 | 2004-04-21 | Glaxo Group Ltd | Compounds |
-
2005
- 2005-03-15 AU AU2005223351A patent/AU2005223351A1/en not_active Abandoned
- 2005-03-15 KR KR1020067021438A patent/KR20060130744A/ko not_active Ceased
- 2005-03-15 US US10/598,838 patent/US7709497B2/en not_active Expired - Fee Related
- 2005-03-15 JP JP2007503404A patent/JP2007529486A/ja active Pending
- 2005-03-15 EP EP05716291A patent/EP1735314A1/en not_active Withdrawn
- 2005-03-15 US US10/598,973 patent/US20080275078A1/en not_active Abandoned
- 2005-03-15 WO PCT/GB2005/000987 patent/WO2005090354A1/en not_active Ceased
- 2005-03-15 RU RU2006132684/04A patent/RU2378274C2/ru not_active IP Right Cessation
- 2005-03-15 EP EP05718039A patent/EP1740590A1/en not_active Withdrawn
- 2005-03-15 WO PCT/EP2005/003038 patent/WO2005090352A1/en not_active Ceased
- 2005-03-15 BR BRPI0508843-7A patent/BRPI0508843A/pt not_active IP Right Cessation
- 2005-03-15 JP JP2007503306A patent/JP2007529464A/ja active Pending
- 2005-03-15 CA CA002559629A patent/CA2559629A1/en not_active Abandoned
- 2005-03-16 AR ARP050101028A patent/AR048175A1/es not_active Application Discontinuation
- 2005-03-16 TW TW094108054A patent/TW200602051A/zh unknown
- 2005-03-16 PE PE2005000299A patent/PE20060078A1/es not_active Application Discontinuation
-
2006
- 2006-09-11 IL IL178011A patent/IL178011A0/en unknown
- 2006-10-02 NO NO20064450A patent/NO20064450L/no not_active Application Discontinuation
- 2006-10-13 MA MA29385A patent/MA28531B1/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007529486A5 (enExample) | ||
| RU2386620C2 (ru) | Производные пиридазин-3(2н)-она и их применение в качестве ингибиторов фдэ4 | |
| JP2007529484A5 (enExample) | ||
| CN103857288B (zh) | 作为激酶抑制剂的氨基-喹啉 | |
| EP3461821B1 (en) | Indole carboxamide compounds useful as kinase inhibitors | |
| CN101641093B (zh) | 作为激酶抑制剂的咪唑并三嗪和咪唑并嘧啶 | |
| RU2497813C2 (ru) | 4-(4-циано-2-тиоарил)-дигидропиримидиноны и их применение | |
| CA2661334C (en) | Pyrimidone compounds as gsk-3 inhibitors | |
| JP2007529485A5 (enExample) | ||
| ATE442367T1 (de) | Pyrazolo(3,4-b)pyridinverbindungen und ihre verwendung als phosphodiesterasinhibitoren | |
| JP2009510043A5 (enExample) | ||
| TW201536791A (zh) | 用於治療囊狀纖維化之新穎化合物及其醫藥組合物 | |
| JP2005510473A5 (enExample) | ||
| CN102883723A (zh) | 治疗化合物及相关的使用方法 | |
| CA2392584A1 (en) | Substituted pyridazines having cytokine inhibitory activity | |
| JP5552121B2 (ja) | ロイコトリエン産生のインドリジン阻害剤 | |
| CN110713489A (zh) | 杂芳基syk抑制剂 | |
| HU208124B (en) | Process for producing pyridazinone derivatives and pharmaceutical compositions comprising such derivatives as active ingredient | |
| MX2008011257A (es) | Derivados de quinolina e isoquinolina como inhibidores de fosfodiesterasa 10. | |
| TW201625581A (zh) | 側氧雜環衍生物 | |
| JP2007528394A5 (enExample) | ||
| JP2007506703A5 (enExample) | ||
| EP3270926A1 (en) | Triazolyl pyrimidinone compounds as pde2 inhibitors | |
| EP3302484B1 (en) | 6-alkyl dihydropyrazolopyrimidinone compounds as pde2 inhibitors | |
| JP2009515950A5 (enExample) |